Avricore Health Pink Sheet Forward View
| AVCRF Stock | USD 0.04 0.01 22.59% |
Avricore Pink Sheet outlook is based on your current time horizon. We suggest always using this module together with an analysis of Avricore Health's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 6th of February 2026 the relative strength index (rsi) of Avricore Health's share price is below 20 . This suggests that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Avricore Health hype-based prediction, you can estimate the value of Avricore Health from the perspective of Avricore Health response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Avricore Health on the next trading day is expected to be 0.03 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.35. Avricore Health after-hype prediction price | USD 0.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Avricore |
Avricore Health Additional Predictive Modules
Most predictive techniques to examine Avricore price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Avricore using various technical indicators. When you analyze Avricore charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Avricore Health Naive Prediction Price Forecast For the 7th of February
Given 90 days horizon, the Naive Prediction forecasted value of Avricore Health on the next trading day is expected to be 0.03 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.000051, and the sum of the absolute errors of 0.35.Please note that although there have been many attempts to predict Avricore Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Avricore Health's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Avricore Health Pink Sheet Forecast Pattern
| Backtest Avricore Health | Avricore Health Price Prediction | Research Analysis |
Avricore Health Forecasted Value
In the context of forecasting Avricore Health's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Avricore Health's downside and upside margins for the forecasting period are 0.0004 and 25.16, respectively. We have considered Avricore Health's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Avricore Health pink sheet data series using in forecasting. Note that when a statistical model is used to represent Avricore Health pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.0733 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0056 |
| MAPE | Mean absolute percentage error | 0.1385 |
| SAE | Sum of the absolute errors | 0.3481 |
Predictive Modules for Avricore Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Avricore Health. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Avricore Health After-Hype Price Density Analysis
As far as predicting the price of Avricore Health at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Avricore Health or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Avricore Health, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Avricore Health Estimiated After-Hype Price Volatility
In the context of predicting Avricore Health's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Avricore Health's historical news coverage. Avricore Health's after-hype downside and upside margins for the prediction period are 0.00 and 25.17, respectively. We have considered Avricore Health's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Avricore Health is out of control at this time. Analysis and calculation of next after-hype price of Avricore Health is based on 3 months time horizon.
Avricore Health Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Avricore Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Avricore Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Avricore Health, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.12 | 25.13 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.04 | 0.04 | 10.91 |
|
Avricore Health Hype Timeline
Avricore Health is presently traded for 0.04. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Avricore is projected to decline in value after the next headline, with the price expected to drop to 0.04. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -10.91%, whereas the daily expected return is presently at 3.12%. The volatility of related hype on Avricore Health is about 0.0%, with the expected price after the next announcement by competition of 0.04. The company recorded a loss per share of 0.01. Avricore Health last dividend was issued on the 21st of November 2016. The entity had 1:4 split on the 21st of November 2016. Assuming the 90 days horizon the next projected press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Avricore Health to cross-verify your projections.Avricore Health Related Hype Analysis
Having access to credible news sources related to Avricore Health's direct competition is more important than ever and may enhance your ability to predict Avricore Health's future price movements. Getting to know how Avricore Health's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Avricore Health may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IDXG | Interpace Biosciences | 0.00 | 0 per month | 5.59 | 0.13 | 15.79 | (10.71) | 54.19 | |
| RNVA | Rennova Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| THCBF | THC Biomed Intl | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ICBU | Imd Companies | 0.00 | 0 per month | 9.83 | (0.0004) | 30.77 | (20.00) | 83.53 | |
| TDSGF | Telo Genomics Corp | 0.00 | 0 per month | 7.16 | 0.01 | 15.63 | (15.00) | 48.57 | |
| BBRRF | Blueberries Medical Corp | 0.00 | 0 per month | 7.71 | 0.05 | 16.83 | (11.50) | 57.95 | |
| PMEDF | Predictmedix | 0.00 | 0 per month | 6.45 | 0.09 | 18.00 | (13.64) | 139.39 | |
| BUDZ | Weed Inc | 0.00 | 0 per month | 9.06 | 0.03 | 22.35 | (17.70) | 57.70 | |
| VDQSF | Gnomestar Craft | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AVTBF | Avant Brands | 0.00 | 0 per month | 3.88 | 0.11 | 7.94 | (7.58) | 19.66 |
Other Forecasting Options for Avricore Health
For every potential investor in Avricore, whether a beginner or expert, Avricore Health's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Avricore Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Avricore. Basic forecasting techniques help filter out the noise by identifying Avricore Health's price trends.Avricore Health Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avricore Health pink sheet to make a market-neutral strategy. Peer analysis of Avricore Health could also be used in its relative valuation, which is a method of valuing Avricore Health by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Avricore Health Market Strength Events
Market strength indicators help investors to evaluate how Avricore Health pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avricore Health shares will generate the highest return on investment. By undertsting and applying Avricore Health pink sheet market strength indicators, traders can identify Avricore Health entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.77 | |||
| Day Median Price | 0.0449 | |||
| Day Typical Price | 0.0449 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
Avricore Health Risk Indicators
The analysis of Avricore Health's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Avricore Health's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting avricore pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 16.96 | |||
| Semi Deviation | 17.24 | |||
| Standard Deviation | 24.41 | |||
| Variance | 595.79 | |||
| Downside Variance | 484.35 | |||
| Semi Variance | 297.27 | |||
| Expected Short fall | (23.05) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Avricore Health
The number of cover stories for Avricore Health depends on current market conditions and Avricore Health's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Avricore Health is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Avricore Health's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Avricore Health Short Properties
Avricore Health's future price predictability will typically decrease when Avricore Health's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Avricore Health often depends not only on the future outlook of the potential Avricore Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Avricore Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 92.6 M | |
| Cash And Short Term Investments | 2 M |
Other Information on Investing in Avricore Pink Sheet
Avricore Health financial ratios help investors to determine whether Avricore Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avricore with respect to the benefits of owning Avricore Health security.